Invention Grant
- Patent Title: Cannabinoid receptor-1 (CB1) monoclonal antibodies
-
Application No.: US14899551Application Date: 2014-06-25
-
Publication No.: US10227406B2Publication Date: 2019-03-12
- Inventor: Peter Coward , Steven A. Moore, Jr. , Shi-Yuan Meng , Mei-Mei Tsai , Chadwick Terence King , Aaron Avraham Nazarian
- Applicant: AMGEN INC.
- Applicant Address: US CA Thousand Oaks
- Assignee: AMGEN, INC
- Current Assignee: AMGEN, INC
- Current Assignee Address: US CA Thousand Oaks
- Agent Chenghua Luo
- International Application: PCT/US2014/044164 WO 20140625
- International Announcement: WO2014/210205 WO 20141231
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
This disclosure relates to CB1 receptor antigen-binding proteins, e.g. antibodies and methods of using the CB1 receptor antibodies. The CB1 receptor antibodies may comprise an antagonistic antibody to CB1 receptors and may be used to treat various health conditions. The health conditions can comprise obesity or diabetes or any disease that benefits from antagonism of the CB1 receptor.
Public/Granted literature
- US20160145333A1 CB-1 RECEPTOR ANTIGEN-BINDING PROTEINS AND USES THEREOF Public/Granted day:2016-05-26
Information query
